✦ LIBER ✦

Indications and Limitations of Class II and III Antiarrhythmic Drugs in Atrial Fibrillation

✍ Scribed by STEFAN H. HOHNLOSER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-Antiarrhythmic Drugs in Atrial Fibri

✍ JAMES A. LALLY; ERIC M. GNALL; JONATHAN SELTZER; PETER R. KOWEY 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Effects of Intravenous Nifekalant, A Cla

✍ TAKAKO MINAMI; SHOJIRO ISOMOTO; KOJIRO NAKAO; NORIHIRO KOMIYA; SATOKI FUKAE; OSM 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

New Antiarrhythmic Drugs for the Treatme

✍ Jörn Schmitt; Joachim R. Ehrlich; Stefan H. Hohnloser 📂 Article 📅 2008 🏛 Urban and Vogel 🌐 German ⚖ 307 KB

Inhibition of IK,AChcurrent may contribu

✍ Niels Voigt; Nadiia Rozmaritsa; Anne Trausch; Thomasz Zimniak; Torsten Christ; E 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

Effects of a novel class III antiarrhyth

✍ Xiang Guo; Chun-Lin Chen; Qian Yang; Yue-Miao Yin; Qi-Dong You; Yi-Qun Tang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

Rate-dependence of antiarrhythmic and pr

✍ J. Weirich; H. Antoni 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 191 KB